Vancheswaran Gopalakrishnan

Statistics

Publications

Citations

20.3K

H-Index

Active since

2014

Affiliations

The University of Texas MD Anderson Cancer Center(Current)

Baylor College of Medicine

AstraZeneca (United States)

Parker Institute for Cancer Immunotherapy

Broad Institute

Vancheswaran Gopalakrishnan is an author at The University of Texas MD Anderson Cancer Center specializing in oncology, immunology, and life sciences.

ORCID

Publications per year

2014–2024

Publications

Gut microbiome modulates response to anti–PD-1 immunotherapy in melanoma patients

Vancheswaran Gopalakrishnan, Luigi Nezi, Alexandre Reuben et al. · Science · 2017 · 4.7K citations · Full text

Life Sciences, Immunology, Oncology +17

B cells and tertiary lymphoid structures promote immunotherapy response

Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao et al. · Nature · 2020 · 2.7K citations · Full text

Life Sciences, Cell Biology, Immunology +16

The human tumor microbiome is composed of tumor type–specific intracellular bacteria

Deborah Nejman, Ilana Livyatan, Garold Fuks et al. · Science · 2020 · 2.4K citations · Full text

Life Sciences, Microbiology, Oncology +14

Defining T Cell States Associated with Response to Checkpoint Immunotherapy in Melanoma

Moshe Sade-Feldman, Keren Yizhak, Stacey L. Bjorgaard et al. · Cell · 2018 · 2K citations · Full text

Life Sciences, Immunology, Oncology +14

Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine

Leore T. Geller, Michal Barzily-Rokni, Tal Danino et al. · Science · 2017 · 1.8K citations · Full text

Medicine, Microbiology, Oncology +16

1–5 of 37